Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009
Dispatch

Chikungunya Virus and Central Nervous System Infections in Children, India

Penny LewthwaiteComments to Author , Ravi Vasanthapuram, Jane C. Osborne, Ashia Begum, Jenna L.M. Plank, M. Veera Shankar, Roger Hewson, Anita Desai, Nick J. Beeching, Ravi Ravikumar, and Tom Solomon
Author affiliations: University of Liverpool, Liverpool, UK (P. Lewthwaite, T. Solomon); National Institute of Mental Health and Neurological Sciences, Bangalore, India (R. Vasanthapuram, A. Desai); Health Protection Agency, Salisbury, UK (J.C. Osborne, J.L.M. Plank, R. Hewson); Vijayanagar Institute of Medical Sciences Bellay, Karnataka, India (A. Begum, M. Veera Shankar, R. Ravikumar); Royal Liverpool University Hospital, Liverpool (N.J. Beeching).

Main Article

Figure 2

Phylogenetic analysis of chikungunya virus (CHIKV) sequences on the basis of partial E1 gene sequence (position 10620–11148 of the prototype CHIKV S27 genomic sequence). Sequences obtained in this study are in boldface. The analysis was performed using MEGA version 4 software (8), by using the neighbor-joining (p-distance) method. The length of the tree branches indicates the percentage of divergence; the percentage of successful bootstrap replicates is specified at the nodes (1,000 replicates).

Figure 2. Phylogenetic analysis of chikungunya virus (CHIKV) sequences on the basis of partial E1 gene sequence (position 10620–11148 of the prototype CHIKV S27 genomic sequence). Sequences obtained in this study are in boldface. The analysis was performed using MEGA version 4 software (8), by using the neighbor-joining (p-distance) method. The length of the tree branches indicates the percentage of divergence; the percentage of successful bootstrap replicates is specified at the nodes (1,000 replicates). ONNV (o’nyong-nyong virus) prototype sequence was included to root the tree. Scale bar indicates number of nucleotide substitutions per site.

Main Article

References
  1. Pialoux  G, Gauzere  BA, Jaureguiberry  S, Strobel  M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7:31927. DOIPubMedGoogle Scholar
  2. Chatterjee  SN, Chakravarti  SK, Mitra  AC, Sarkar  JK. Virological investigation of cases with neurological complications during the outbreak of haemorrhagic fever in Calcutta. J Indian Med Assoc. 1965;45:3146.PubMedGoogle Scholar
  3. Mazaud  R, Salaun  JJ, Montabone  H, Goube  P, Bazillio  R. Acute neurologic and sensorial disorders in dengue and chikungunya fever. Bull Soc Pathol Exot Filiales. 1971;64:2230.PubMedGoogle Scholar
  4. Parola  P, de Lamballerie  X, Jourdan  J, Rovery  C, Vaillant  V, Minodier  P, Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis. 2006;12:14939.PubMedGoogle Scholar
  5. Yergolkar  PN, Tandale  BV, Arankalle  VA, Sathe  PS, Sudeep  AB, Gandhe  SS, Chikungunya outbreaks caused by African genotype, India. Emerg Infect Dis. 2006;12:15803.PubMedGoogle Scholar
  6. Mavalankar  D, Shastri  P, Bandyopadhyay  T, Parmar  J, Ramani  KV. Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis. 2008;14:4125. DOIPubMedGoogle Scholar
  7. Edwards  CJ, Welch  SR, Chamberlain  J, Hewson  R, Tolley  H, Cane  PA, Molecular diagnosis and analysis of Chikungunya virus. J Clin Virol. 2007;39:2715. DOIPubMedGoogle Scholar
  8. Tamura  K, Dudley  J, Nei  M, Kumar  S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:15969. DOIPubMedGoogle Scholar
  9. Cardosa  MJ, Wang  SM, Sum  MS, Tio  PH. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol. 2002;2:9. DOIPubMedGoogle Scholar
  10. Pyke  AT, Smith  IL, Van Den Hurk  AF, Northill  JA, Chuan  TF, Westacott  AJ, Detection of Australasian flavivirus encephalitic viruses using rapid fluorogenic TaqMan RT-PCR assays. J Virol Methods. 2004;117:1617. DOIPubMedGoogle Scholar
  11. Schuffenecker  I, Iteman  I, Michault  A, Murri  S, Frangeul  L, Vaney  MC, Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3:e263. DOIPubMedGoogle Scholar
  12. de Lamballerie  X, Leroy  E, Charrel  RN, Ttsetsarkin  K, Higgs  S, Gould  EA. Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virol J. 2008;5:33. DOIPubMedGoogle Scholar
  13. Tsetsarkin  KA, Vanlandingham  DL, McGee  CE, Higgs  S. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3:e201. DOIPubMedGoogle Scholar
  14. Rampal  SM, Meena  H. Neurologic complications in Chikungunya fever. J Assoc Physicians India. 2007;55:7659.PubMedGoogle Scholar
  15. Wielanek  AC, Monredon  JD, Amrani  ME, Roger  JC, Serveaux  JP. Guillain-Barré syndrome complicating a Chikungunya virus infection. Neurology. 2007;69:21057. DOIPubMedGoogle Scholar
  16. Robin  S, Ramful  D, Le Seach  F, Jaffar-Bandjee  MC, Rigou  G, Alessandri  JL. Neurologic manifestations of pediatric Chikungunya infection. J Child Neurol. 2008;23:102835. DOIPubMedGoogle Scholar
  17. Beasley  DW, Lewthwaite  P, Solomon  T. Current use and development of vaccines for Japanese encephalitis. Expert Opin Biol Ther. 2008;8:95106. DOIPubMedGoogle Scholar
  18. Global Advisory Committee on Vaccine Safety. 29–30 November 2006. Wkly Epidemiol Rec. 2007;82:1824.PubMedGoogle Scholar
  19. Grivard  P, Le Roux  K, Laurent  P, Fianu  A, Perrau  J, Gigan  J, Molecular and serological diagnosis of Chikungunya virus infection. Pathol Biol (Paris). 2007;55:4904. DOIPubMedGoogle Scholar

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external